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Summary 4 days after portacaval shunt, the livers 
of normal dogs had pronounced atrophv 
and other structural abnormalities. These changes were 
greatly reduced in the left liver lobes, but not in the 
right, by a constant infusion to the left portal vein of in-
sulin in non-hypoglyczmic doses. These experimental 
findings should have implications in clinical medicine. 
ISTRODl:CTIOS 
DURING the past ten years we have developed evidence 
that substances, termed hepatotrophic factors, in the 
portal venous blood of dogs can profoundly influence 
liver function as well as the size, internal structure, 
chemical composition, and dividing capability of the 
hepatocytes. 1-' In most of these experiments, techniques 
were exploited that permitted comparative study of two 
portions of the same liver which were given different 
kinds of portal venous inflow under diabetic or non-dia-
betic conditions. The concept emerged that manifold 
hepatic processes are controlled or influenced by hor-
mones that are generated by splanchnic organs and deli-
vered straight to the liver, with a presumably augmented 
significance because of the episodically high concentra-
tions of nutrient substrate in the same blood. 2-' Insulin 
has' been identified as the most important of these un-
doubtedly multiple portal hepatotrophic constituents. O·~ 
If the foregoing conclusions were correct, the ztiology 
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EFHCT OF ISSI'LIS ISFl'SIOS OS HEPATOC:YTE SIZE AFTER PClRTA!:,\\'AI. 
SHt'ST IS DClGS 
---
Hepatocyte' size ~ size uniu)· 
Insulin dose mean + standard de"iation 
'<0. of (unitslkg./day) 
--
E~roup dolt" mean" '.Il. LOt L4t R4t 
-
1 8 Sone 0·196,0-048 0·108' 0-024 0- \08' 0-024 
2 9 0-44' 0·04 0-\96-0·036 0-\57' 0·024 0·106' 0-023 
3 4 0-\6+0·\1 0-\94+0·037 o· \43·0-022 0·094' 0-007 
-
"The control left lobe biopsies (LO) were accepted as pretreatment controls for 
the ri~ht lobes as wcll. since hepatocytcs in the two sides have been shown to 
be the same in normal doltS. l .. 
tl.O left-lobe biopsy al ,illl. of ponacaval shunt_ L4 left·lob. when killed 
,,1',", ~ ,Ia\·,. R4 oi~ht lobe when kilk-d .ftcr 4 da~·sK 
of the well-recognised but poorly understood hepatic in-
jury caused by portacaval shunt in animals would 
become explicable. Furthermore, it should be possible to 
minimise this damage by infusing insulin into the liver 
from which portal flow has been diverted. We have per-
formed this experiment in dogs with results that should 
have clinical implications. 
METHODS 
Eight normal mongrel dogs averaging about 19 kg had large 
side-ta-side portacaval shunts (group I)_ The shunts were 
made completely diverting by ligating the right and left portal 
branches at their origin. Thirteen more dogs of approximately 
the same weight had the same procedure except that the tip of 
a fine infusion catheter was placed into the tied-off left portal 
branch and led outside to a small finger pump that was incor-
porated into a light body cast. A pump infusion of regular in-
sulin diluted in heparinised physiological saline was started, 
using volumes that never exceeded 21 ml/day. The thirteen 
test dogs were divided into two subgroups of nine (group 2) 
and four (group 3) on the basis of the insulin dose that was 
given (see accompanying table). Ten normal dogs in our 
laboratory had morning blood-sugars of 61·1-!9·2 (S.D.) 
mg/dl. The nine test dogs receiving the larger dose of insulin 
for 4 days had 30 morning blood-sugar concentrations that 
were 64·8± 13·0 (S.D.) mg/dl. The four dogs treated with low 
insulin doses had 13 sugar determinations of 71·2,:8·4 (S_D.) 
mg/dl. All dogs were on an ad-libitum diet from the 1st post-
operative day onward. 
The experiments lasted 4 days_ Their design permitted an 
evaluation of any direct protective effect of 
insulin upon the left lobar hepatic tissues as 
well as a judgment whether insulin which 
passed through the left lobes without being 
consumed or degraded had a spillover effect 
upon the right side after recirculation. His-
topathological end-points were used. The 
size of the hepatocytes was determined on 
hzmatoxylin-and-eosin-stained sections by 
a method previously described. l In essence, 
the technique cORsists in tracing out large 
numben of hepatocytes on standard-thick-
ness paper, entting out the silhouettes, and 
weighing them. The weights were desig-
nated as size units. Methods for other light 
and electron microscopic examinations that 
were made in selected experiments were as 
described before.l 4 , 
RESULTS 
arm of portacaval IbtIDt: liver biopsies from (a) ... tlDtreated dOl aad (b) • dOl whose tied-olr 
Ieft-portal-veill braDCb .... coa.taatly iafllied with iDsulia. 
The insulin infusions into the left 
portal vein reduced markedly but did 
not completely prevent atrophy in the 
left lobes (table and figure). The pro-
tective effect occurred with both 
~ote the protection by direct insulin infusion (L4 [bl.) Hzmatoxylin and eosin. Reduced by 




higher and lower insulin dose ranges, but somewhat less 
with the low doses. There was no spillover protection 
whatever for the right lobes (table). The differences in 
the day-4 left lobar biopsies between all thirteen treated 
dogs versus the eight controls were significant (p<O·001) 
as were the differences between the day-4 left-versus-
right lobar biopsies in the pooled thirteen treated ani-
mals (p<O·OOl). 
The maintenance of the size of the hepatocytes in the 
left lobes of the animals treated with insulin was not due 
to an accumulation of fat or glycogen in the cytoplasm 
(figure). This was confirmed by electron microscopy 
which showed that these hepatocytes had an essentially 
normal ultrastructure. In contrast, the atrophic right-
lobe hepatocytes showed an increased number of small 
lipid vacuoles and other inclusion bodies, reduction in 
amount and dilatation of the rough endoplasmic reticu-
lum, and swelling of the mitochondria. 
D1SC17SSIOS 
These experiments were planned after it was realised 
in earlier work with what remarkable rapidity liver tis-
sue in dogs was altered if it was denied exposure to 
either total splanchnic venous blood or that portion of 
it which returns from the pancreas.s Thus, it was not 
surprising that in untreated control animals hepatocyte 
atrophy and other morphological changes within 4 days 
after portacaval shunt were almost as pronounced as 
those we have seen 2 months after this operation. 3 l'or 
was it unexpected that intraportal insulin in non-hypo-
glyCEmic doses sharply reduced these structural abnor-
malities in the liver lobes directly exposed to the infu-
sion, but not in the contralateral lobes-presumably 
because the liver avidly removes insulin on first pass.6 
The failure of insulin to completely protect even the di-
rectly infused liver probably means that other indivi-
dually less important substances in splanchnic blood 
have a Significant composite, hepatotrophic effect as we 
have suggested in the past from other lines of evi-
dence. l - l 
The concept of an interplay between the liver and the 
other splanchnic organs in which the liver is the target 
and not iust the monitor and integrator of hormonal 
messages has many specific implications apart from a 
broader understanding of hepatic physiology. It has 
already permitted an approach to such diverse clinical 
issues as the correct revascularisation of liver homo-
grafts;l the means by which portal diversion can benefit 
patients with hyperlipidzmia 3 7 and glycogen-storage 
disease;8 the mechanism by which portal blood affects 
liver regeneration;! 9-11 and the proper selection of 
shunt procedures to decompress a:sophageal varices. 
The observations of this report hold open twO addi-
tional possibilities of investigation. First the therapeutic 
effect of intraportal insulin alone and in combination 
with other possible collaborating hepatotrophic sub-
stances (such as glucagon) should be investigated in 
appropriate animal models of acute liver injury other 
than the Eck fistula preparation which we used. It 
would be surprising if the course of recovery from other 
kinds of iniury could not be influenced. Second, the 
same approach of hormone therapy should be evaluated 
in an attack on the root cause of the hepatic encephalo-
pathy that can occur in animals and man with liver fail-
ure or after completely diverting portacaval shunt. Past 
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efforts have tended to focus upon the toxic products 
causing the encephalopathic syndromes rather than 
upon the organ whose malfunction is responsible. 
This work was supported by research grants from the \' <teran, 
Administration; by grants AI-AM-08898 and AM-07772 from the 
National Institutes of Health; by grants RR-00051 and RR.00069 
from the general clinical research centers program of the Divi5ion of 
Research Resources, National Institutes of Health; and by a grant 
from the Medical Research Council of Great Britain. 
Requests for reprints should be addressed to T. E. S., Department 
of Surgery, Cniversity of Colorado Medical Center, Denver, Colorado 
'80220, C.S.A. 
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IMMUNOTHERAPY OF NON-CLINICAL 
VAGINAL CANCER 
D. GUTHRIE S. WAY 
Depamnem of Gyn«c%gical Oncology, Queen Elizabeth 
H ospiral, Gateshead, and Department of Obstetrics and 
Gyn«coJogy, University of Newcascle upon Tyne 
Summary In six women who had had a hvsterec-
tomy and three or more vaginal smears 
positive for malignant cells but no symptoms, a course 
of immunotherapy, based on delayed hypersensitivity 
reaction to dinitrochlorobenzene, was tried. Repeat 
smears done every three months have all been normal, 
and the patients were well when last seen 2-35 months 
after treatment. 
INTRODUCTION 
IN patients who have had a hysterectomy, the 
appearance of malignant cells in a vaginal smear with-
out clinical evidence of cancer presents a problem. 
Skilled colposcopic examination of the vagina may 
demonstrate the site of the microscopic lesion, allowing 
local surgery to be done, but usually, in the absence of 
a colposcope, the whole vagina is removed with or with-
out vaginal replacement, depending upon the patient'S 
sexual needs. 
In 1968, Klein described a method of immunotherapy 
of cutaneous and mucosal neoplasms I based on the 
delayed-hypersensitivity response to triaziquone ('Treni-
mon'). Following correspondence with Dr Klein, we 
have used the delayed-hypersensitivity response to 
D.N.C.B. (dinitrochlorobenzene) in an attempt to treat 
non-clinical vaginal cancer. 
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PATIENTS ASD METHODS 
Patients 
All seven patients had had a hysterectomy, and before 
D.N.C.B. treatment all had at least three vaginal smears show-
ing the presence of malignant cells, confirmed by at least two 
independent cytologists. Full examination of the vagina did 
not reveal any evidence of invasive cancer or any other sus-
picious lesion. 
Methods 
Patients were given a tube of 0·1% D.I'.C.B. in simple 
aqueous cream base, and told to apply a small amount of 
cream at least once daily inside a circle 1 em in diameter 
drawn on either an arm or leg, and to ensure that there was 
always some eream in contact with their skin at that point. No 
dressing was applied. The patients were told to expect a reac-
tion to the cream at the site of application after 3 or 4 weeks, 
this reaction usually consisting of some redness of the skin and 
local irritation although occasionally blistering occurred. Pa-
tients were told to stop applying the cream as soon as they got 
a reaction. The degree of sensitivity was then assessed by 
applying four different concentrations of D.N.C.B. (0·1%, 
0·05%, 0·005%, and 0·0005%) in four adjacent areas of the 
skin, twice in a period of 48 h.The patch tests were covered by 
a simple dressing. After 48 h that concentration of DoS.C.B. 
which only just produced a reaction was chosen and used for 
local application to the vagina. 
The vulval area was liberallv coated with sterile white 
paraffin, in an attempt to prevent local reaction on the vul~a 
from vaginal spillage. Using a 20 mI syringe and a firm plastic 
tube, 14 mI of tbe chosen concentration Of.D.S.C.B. in simple 
cream was inserted at the vaginal vault. This cream was tben 
distributed over the whole vaginal surface by digital means 
using a surgical glove. Applications were made daily until 
there was intense local reaction in the vagina or for 3 succes-
sive days, whichever came earlier. The patient was nursed in 
bed and, after using a bedpan or on any occasion when it was 
fclt there may be spillage of D.N.C.B. onto the vulva, the vulval 
area was swabbed and white paraffin was liberally reapplied. 
24 h after treatment was completed the patient was allowed 
up, and, provided she could cope with vulval swabbings, she 
was discharged. Each patient was advised that for 1 week after 
leaving hospital she should not go swimming or sit in a bath 
in case water entered the vagina. Patients were advised to 
abstain from sexual activity until they were seen again for 
repeat cytology 6 weeks later. Cytological examination was 
then repeated every 3 months for the first 2 years and then 
every 6 months thereafter. 
RESULTS 
Of seven patients, one did not become sensitised to 
D.N.C.B. even after continuous daily application for 5 
months, and this method of treatment was abandoned in 
her case. 
The remaining six patients all had normal smears at 
follow-up and they have remained normal since. Individ-
ual follow-up has been for 35, 27, 24, 17, 13, and 2 
months so far. 
No side-effects have been noted as a result of this 
treatment, other than some vulval discomfort, as the 
white paraffin is not completely effective in preventing 
reaction on the vulva. 
DISCUSSION 
Not all intraepithelial carcinomas progress to invasive 
clinical cancer-indeed a small percentage of such 
lesions may regress completely, such regression probably 
being immunological in origin. It is presumed that the 
local infiltration of the vagina by sensitised lymphocytes 
in the treated patients is similar to that which occurs 
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naturally in those patients where the lesion regresses 
spontaneously. We believe that the treatment we have 
described should be applied to any patient with a non-
clinical vaginal malignancy, surgery being undertaken 
only if immunotherapy fails. 
We have also treated many patients with carcinoma-
in-situ of the cervix by a very similar method. The 
results are not so straightforward as with non-clinical 
vaginal cancer, however, and seem to depend on the 
amount of cervical mucus present and on the exact site 
of the lesion. Further work is required before we feel 
able to publish results of immunotherapy for this much 
more common condition. 
Requests for reprints should be addressed to D.G., Queen Elizabeth 
Hospital, Gateshead NE9 6SX. 
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Hypothesis 
FUNCTIONAL SUBDIVISION OF ISLETS OF 
LANGERHANS AND POSSmLE ROLE OF D 
CELLS 
Lnlo ORCl 
Institute of Hiscology and Embryology, Geneva, Su.'itzerland 
ROGER H. t:SGF.R 
Veterans Administration Hospital and University of Texas 
Southu:escern Medical School, Deparcmenc of Medicine, 
Dallas, Texas. U.s.A. 
Summary ImmunocVlochemical examination of 
the islets 'of Langerhans in various ani-
mal species, including man, indicates that insulin-pro-
ducing cells (B cells), glucagon-producing cells (A cells!, 
and cells producing somatostatin or a somatostatin-like 
peptide (D cells) are not randomly arranged within the 
islet. Whenever A cells are found in the islet-i.e., 
mostly in its peripheral part-they are accompanied by 
D cells. However, most B cells, which occupy a central 
position, are in contact only with other B cells. In view 
of the inhibitory effect of somatostatin on both insulin 
and glucagon secretion, it is suggested that the arrange-
ment of A, Band D cells is important to the normal and 
pathological functioning of the islet. 
THE islets of Langerhans are clusters of endocrine 
cells which respond as single functional units to various 
physiological influences. The re::~!1l demonstration of 
junctional complexes between ac:acent islet cells! has 
raised the possibility that cell-to-cell communication 
may help to coordinate their hormonal outputs. We pro-
pose, therefore, the concept, based entirely on anatomical 
findings, that the islet of Langerhans may be func-
tionallv divided into twO subunits-one, a peripheral 
hetero~ellular unit, composed of A, B, and D cells, in 
which somatostatin release from D cells can inhibit glu-
cagon and insulin secretion from the neighbouring A 
and B cells; the other, a centrally located homocellular 
unit, composed mostly ofB cells. 
The discovery that somatostatin,2 a powerful inhibi-
tor of both insulin and glucagon secretion,3-a or a soma-
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tostatin-like immunoreactive material is present in the 
islets of Langerhans,9-12 more precisely in 0 cells,13-17 
led us to re-evaluate by immunofluorescence techniques 
the arrangements of insulin, glucagon, and somatostatin 
containing cells. A most striking feature in all species ex-
amined was the parallel distribution of A and 0 cells, 
which seemed far too consistent to be a coincidence. In-
deed, in the rat, Chinese hamster, and mouse, in which 
the glucagon-producing A cells occupied the most peri-
pheral area of the islets, the 0 cells formed a sparser 
layer in close proximity to the outer A-cell sheath, and 
peripheral to the great mass of the centrally located islet 
cells composed mostly of B cells (see accompanying 
figure). In species, such as the horse, in which the A cells 
were concentrated in the centre of the islets, the 0 cells 
also were more centrallv distributed. Finallv, in man, in 
addition to their generally peripheral locati~nI A and 0 
cells tended to be grouped together against capillary 
walls as clearly delineated cell cords within the islets. 
It follows that the percentage of the tolal A-cell mass 
in contact with 0 cells must be greater than the percent-
age of the B-cell mass, most of which has no O-cell con-
tacts. Consequently, if islet somatostatin functions as a 
local inhibitor of neighbouring A and B cells, it would 
have a greater influence upon pancreatic glucagon secre-
tion than on insulin secretion. Similarly, glucagon could 
have a greater effect than insulin upon pancreatic soma-
tostatin secretion. Onlv those B cells in or near the 
heterocellular rim of the islet containing A, D, and B 
cells would be affected bv locallY secreted somatostatin. 
Could there, then, be t~o anatomical and functional 
subunits of the islets of Langerhans, a heterocellular (A, 
Band 0 cells) "cortex", where vascular and neural ele-
ments abound and D cells are prominent, and a predo-
minantly central region, consisting mainly of B cells? 
The heterocellular region of the islets of Langerhans 
could be the acutely responsive dynamic component 
which participates in the rapid moment-te-moment 
changes in insulin and glucagon release. The so-called 
first phase of insulin release, a sudden but short-lived 
burst, could originate in this region and be quickly 
quenched by somatostatin release. Inhibition of gluca-
gon secretion by insulin 18 19 and of insulin secretion by 











Schematic representatioo of AI'l islet of LaJl3erbaas showin«' distribution 
of glucagon, somatostatin, and insulin containiD.g cells. 
lslet-cell tvpes for whIch no positive function has yet been estab-
lished are ommcd. 
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homocellular B-cell mass, bv contrast, could be a less 
dynamic, but steadier, site of insulin production, carrv-
ing the burden of the continuing basal and anabolic ho-r-
mone requirements. 
In addition to their anatomical prOXlnllty, a 
quantitative relationship between A and 0 cells appears 
to exist. Whenever the A cells were found in great abun-
dance---e.g., in "dark islets" of birds,13 in human juve-
nile diabetes,21 22 and in streptozotocin diabetic 
rats l7 21 22_0 cells were correspondingly abundant. In 
the only glucagon-secreting tumour thus far studied in 
this manner, a considerable increase in somatostatin-
staining 0 cells was found exceeding even the adjacent 
A celIs. l7 21 So far, somatostatin-containing cells have 
been found in the absence of glucagon-containing cells 
only in the canine uncinate process.21 
The correlation between A and 0 cell numbers 
accords with the postulated inhibitorv action of D cells 
upon A-cell secretion. For instance, -the intense D-cell 
hyperplasia observed in some diabetic states, and in a 
glucagon-secreting tumour could reflect a compensatory 
response of the D cells, however ineffective, to reduce 
excessive glucagon release caused respectively by insulin 
lack or autonomous function by malignant A cells. 
Although the possibility that insular somatostatin 
does not leave the islets will make this hypothesis diffi-
cult to test, these concepts warrant serious consideration 
in physiological and pathophysiological issues involving 
the islets of Langerhans, and a possible role of the 0 cell 
as a mediator of negative effects on glucagon and insulin 
secretion should now be entertained. 
This work was supported by Fonds National Suisse de la Recherche 
Scientifique grant no 3.553.75, and by National Institute, of Health 
grant no AM 02700-15. 
Requests for reprints should be addressed to L. 0., Institut d'H ista-
logie el d 'Embryologic, Ecole de M':decine, 1211 Geneve 4, Suisse. 
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Insulin and the Liver 
THE first major impact of the pancreatic hor-
mones, insulin and glucagon, is on the liver 
through the ponal system. Why should pancreas 
and liver be so closely related anatomically? The 
liver destroys half or more of the insulin in pona1 
blood, 1 so it obviously has a degradative function, 
and insulin may also be lost in the bile. % Insulin 
concentrations bathing liver are some two to four 
times those reaching the periphery,1 and this obser-
vation led to the view that the relation of pancreas 
to liver has a major regulatory influence on inter-
mediary metabolism.3 4 In particular, the relation 
will be imponant in the disposal of ingested fuels 
reaching the liver via the pona1 route. S More 
recently the simple view that insulin alone deter-
mines the way that the liver disposes of circulating 
fuels has been replaced by a concept giving prime 
importance to the insulin/glucagon ratio.6 Experi-
ments by PARILLA and his colleagues7 showed no 
difference in the effects of insulin and glucagon 
over a wide concentration range provided that the 
ratio of the two hormones was kept constant. 
UNGER6 has also shown that the glucagon/insulin 
ratio changes according to whether the organism 
requires the liver to produce or to conserve fuel, 
although the imponance of glucagon relative to in-
1. Blaclean!, W. G., Nelson, N. C. ailzb~ .. s, 1970, 19, 302. 
2. Karran, S., Hiebert, J., Egdah1, R. H. Sur/l. Forum, 1973,24,92. 
3. Felig, P., Wahrcn, J.]. ,Ii". 1".,.".1971, 50,1702. 
4. Felig, P., Wahrcn, J. Isr.]. m.d. Sg. 1975,11,528. 
5 .. \l,adison, 1.. L.Archs i,,' ....... M.d. 1969,123,284. 
6. t.:ngcr, R. H. Dilzb.w, 1971,20, 834. 
7. Parilla, R., Goodman, M. N .• Toews. C. J. ibid. 1974,23.725. 
8. t.:ngcr. R. H., Ora. L. Lam:." 1975, i, 14. 
9. Barnes, A. J .• Bloom ...... Crowley. M., Tuulebee, J. \t ..• Bloom, S. R., 
Alberti, K. G. M. M .• Smythe, P., Tumell. D. ibid. 1975, ii, 734. 
10 .. \l,an:hioro, T. 1.., Poncr. K. A., Dicltinson. T. C., Faris. T. D., S,anl, T. 
E. Sur/lery G)I""' Ob".,. 1965, Ul, 17. 
11. .\l,arehioro. T. L., Poncr. K ..... , Brown. B. 1., Oue, j.-B .• Stanl, T. E. Sur-
/lery, 1967.61.723. 
12. Broelsch, C. E., Lee, S., Charters. A. C. 11I, Chancllcr, ]. G., Gramhort, D. 
E., Orloff, .\l,. J. Sur/l. Forum, 1974,25,394. 
13. Popper. H. G ... ",om,crolo/cy, 1974,66, 1227. 
14. Sil!Cl, B.]. surl/. Res. 1969,9,387. 
15. Sgro, J.-C., Chanen, A. C., Chancllcr, J. B., Grambort, D. E., Orloff, M. 
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J. S. Najarian and J. P. DclaDcy); p. 495. Sew York, 1974. 
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sulin in diabetes mellitus8 may' have been over-
stated.9 
An entirely different role of insulin has now 
been revealed. Over the past decade workers in 
various laboratories have sought the nature of elu-
sive "hepatotrophic" factors which are present in 
ponal venous blood.10- 19 These factors seem to 
affect many aspects of the hepatocyte including 
regeneration, cell size and structure, and lipid 
metabo1ism.20 The presence of hepatotrophic fac-
tors was suggested 55 years ago by Rous and 
LARIMORE21 but it is only lately that, with the aid 
of ingenious surgical techniques, suggestions have 
been made as to their nature. Much of the newer 
work has come from MARCHIORO, PORTER, 
PUTNAM, STARZL, and their colleagues,lo 11 16-19 
and it stemmed from studies on the revascularisa-
tion of auxiliary liver grafts. 10 Two parts of the 
same liver were maintained with ponal venous in-
flow of splanchnic or systemic bloocl. The part of 
the liver perfused with splanchnic blood showed 
strikingly greater hyperplasia, hypenrophy, and 
glycogenation. Subsequent experiments produced 
hepatocyte atrophy in dogs after ponacaval trans-
position in which lower limb and renal venous 
blood was divened to the liver.ll 17 This neatlv 
negated the suggestion that the hepatic atrophy 
seen after portacaval shunting is due to decreased 
flow%% and strongly supported the role of some 
chemical factor or factors. In other experiments 
one part of the liver was supplied by blood pri-
marily from the lower splanchnic bed while the 
other part of the liver received blood from the pan-
creatico-gastroduodenal bed.16 There were drama-
tic differences between the two parts of the liver. 
That part receiving pancreaticoduodenal blood 
showed obvious hypenrophy and hyperplasia as 
early as four days after the operation 19 while the 
lobe receiving lower splanchnic blood showed pro-
nounced atrophy, although this was not as severe 
as in the ponal-transposition experiments. Again, 
flow was not a limiting factor. %3 This led to the 
suggestion that the pancreatic hormones insulin 
and glucagon were all-important, with some 
smaller contribution from lower splanchnic blood 
due presumably to its high substrate content. How-
ever, when alloxan-diabetic dogs were used the 
beneficial effects of pancreatic blood were lost, de-
spite the presence of glucagon, and no difference 
was found between pancreatectomised and alloxan-
diabetic animals. 11 Suggestions to the contrary 
notwithstanding,l4 %5 this seemed to eliminate glu-
cagon and left insulin as the probable major factor. 
20. Starzl. T. E., Lee. I. Y .• Poner, K. A •• Putnam. C. \t •. ibid. 1975.140,381. 
21. Rous, P .• Larimore, 1.. D.]. up. M~dK 1920.31,609. 
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Dr STARZL and his colleagues in this issue (p. 1241) 
now provide direct evidence that insulin is indeed 
a major factor in maintaining hepatic integrity in 
vivo. In their delightfully simple experiments they 
confirm first that portacaval shunts in dogs lead to 
hepatic atrophy. They have then repeated these 
experiments but infused a small amount of insulin 
(insufficient to cause hypoglycremia) into the left 
portal vein and observed a decrease in hepatocyte 
shrinkage which could not be accounted for by gly-
cogen deposition. This, the preceding work by 
STARZL and his colleagues, and previous in-vitro 
workl6 suggest strongly that insulin may have a 
crucial role in maintenance of hepatocyte integrity 
and also in hepatic regeneration, although it would 
be rash to suggest that other factors are not in-
volved as well. 
This work, if confirmed in man, has distinct 
clinical implications. STARZL points out some of 
these, including the possible value of intrapor-
tal insulin in acute liver injury. He makes the intri-
guing suggestion that the hepatic encephalopathy 
which follows portacaval shunting or severe liver 
failure may be due to lack of normal effects of insu-
lin and other hepatotrophins on the liver. One can 
also envisage a vicious circle in chronic liver dis-
ease: as diversion of portal blood becomes greater, 
so the ability of diseased hepatocytes to regenerate 
will become less with the decrease in insulin deli-
very. Other implications are clear. Diabetes mel-
litus is treated by extraportal injection of insulin. 
REAVEN and clrworkersl7 showed that alloxan dia-
betes in the rat caused considerable changes in 
hepatocyte ultrastructure. Although YOUNGER et 
al.,28 many years ago, showed that insulin treat-
ment of alloxan-diabetic animals caused a proli-
ferative hepatic response, STARZL and his col-
leagues have shown elsewhere that subcutaneous 
insulin could not entirely reverse the effect of pan-
createctomy or alloxan diabetes on hepatocyte 
growth and structure. Hepatic cirrhosis is more 
common in diabetic patients than in the non-diabe-
tic population,l9 while fat deposition in hepatocytes 
is a common concomitant of diabetes. It is possible 
that the low portal-insulin concentrations which 
accompany systemic insulin therapy are a major 
factor. The relative insensitivity of the diabetic to 
systemic insulin may indeed be of value in preserv-
ing hepatocyte structure and function. TCHOB-
ROUTSKy30 has shown that peripheral insulin con-
centrations of two to three times normal are 
required to maintain normoglycremia when insulin 
is given systemically. This means that hepatic-ar-
tery concentrations will be higher than normal and 
may help substitute for the deficient portal insulin. 
26. Ldfen, J. L.J. Cell Bioi. 1974, 6l, 792. 
27. Reaven, E. P., Peterson, D. T., Reaven, G. M. J. eli •. fn~K"K 1973,52, 248. 
28. Younll"r, L. R., King, J., Steiner, D. F. Cancer Res. 1966,26, 1408. 
29. Creutzieldt, W., French, H., Sickinger, K. Prof(. ii~er Dis. 1970. 3, 371. 30. Tchobroutsky, G. in Diabetes. ieditcd by W. J. MalalSS< and J. Piran); p. 
667, Amsterdam, 1974. 
THE LANCET, DECEMBER 20,1975 
Further work is obviously needed to establish the 
effects on the hepatocyte of systemic insulin, but 
they are unlikely to be beneficial. A comparison in 
diabetic animals of the effects on the hepatocyte of 
islets transplanted into the portal system versus 
islets transplanted into the extra portal system 
should provide an answer. STARZL'S results should 
provide another spur to those seeking "physiologi-
cal" replacement of insulin in diabetes. We should 
also perhaps look afresh at the use of portal-shunt 
operations for metabolic diseases such as glycogen-
storage disease31 3l and intractable familial hyper-
cholesterolremia.33 The operation may be life-sav-
ing, in part at least because of diversion of insulin, 
but it should perhaps be reserved for potentially 
fatal cases in view of the long-term hepatic atrophy 
that may follow, owing to that selfsame diversion 
of insulin. As a final thought, it is intriguing that, 
even with such a hackneyed hormone as insulin, a 
new role can still be found and a new and convinc-
ing explanation given for the close anatomical rela-
tion of the pancreas and the liver. 
Glycerol in Acute Cerebral Infarction 
THE list of methods which have been tried for 
the treatment of acute cerebral infarction vies in 
length with that for multiple sclerosis, reflecting 
the ineffectiveness of current therapy in both situa-
tions. Anticoagulants,34 3S cortisone,36 37 stellate-
ganglion block,34 low-molecular-weight dex-
tran,38-40 vasopressor drugs,41 dexamethazone4l43 
and prolonged artificial hyperventilation" have all 
been tried for acute cerebral infarction with vary-
ing and, often conflicting, results. It might be said 
that disappointment was inevitable because infarc-
tion means the death of neurons, so there is 
nothing to be saved. This view overlooks two im-
portant factors. The first is the contribution of 
cerebral redema to the mortality and morbidity of 
cerebral infarction. An infarction of appreciable 
size provokes redema formation in surrounding tis-
sue, causing further harassment to the damaged 
brain. Prevention or control of redema might be 
31. Stard, T. E., Putnam, C. \l'ot POMer, K. A., Haigrimson, C. G., Corman, 
J., Brown, B. I., Gotlin, R. W., Rodgenon, D.O., Greene, H. L. Ann. 
SurK. 1973,178, 36. 
32. RiddeU, A. G., Davies, R. P., Clark, A. D. Lane .. , 1966. ii, 1146. 
33. Starzl, T. E., Chase. H. P., Putnam, C. W., Poner, K. A. ibid. 1973, ii, 940. 
H. Caner, A. B. Q. Ji M.d. 1959, l8, 125. 
35 .. \\arshaU, J., Shaw, D. A. Lancel. 1960. i. 995. 
36. Dyken, M., White, P. T.J.Am. med.Ass. 19l6.162, Il31. 
P~K Chandler, G. N .• Clark, A. N. G., Higgins, F. E .• !'oiewcombe, C. P., 
Taverner, D. dero~loiogKaI 1957,5,717. 
38. Gilroy, T., Barnhan, M. J. and Meyer, J. S. J. Am. med. Ass. 1969,210, 
293. 
39. Spudi .. E. \'., de I. Torre, E., Pikula, L. S,ro ••• 1973.4, 895. 
40. Gottstein, C., Scdlmeyer, I. Research on the Cerebral Circulation: Seventh 
International Salzburg Conference (in the press). 
41. Wise, G., Sutter, R., Burkholder, J. S'ro ••• 1971,2. 135. 
..2. Patten, B. M., ,\ttendell, 1., Bruun, B., Curtin, 'X/., Caner, S. NeuroJoK,Y. 
1972,22, 377. 
43. Bauer, R., TeUez, H. Stro •• , 1973,4,547. 
44. Christensen, M. S., Paulson. O. B., Olesen, J., Alexander, S. C., SkiDh0;, E., 
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expected to lessen damage. The second factor is 
that not all tissue affected by the primary vascular 
lesion is infarcted; some is ischlEmic. 
HOSSMANN 4S 46 has shown that neurons which have 
been rendered ischlEmic for a matter of some hours 
may recover their ability to produce evoked poten-
tials and to resume metabolic activity. There is 
therefore a rational basis for further attempts to 
treat acute cerebral infarction. 
The most recent of these employs intravenous in-
fusions of 10% glycerol in glucose or saline daily 
for four or six days. The claim is made that gly-
cerol not only reduces redema by acting as a 
hyperosmolar agent but also improves cerebral 
metabolism. Cerebral blood-flow is increased, 
oxygen consumption and carbon dioxide produc-
tion by the brain are decreased, glucose consump-
tion remains constant, whilst the respiratory quo-
tient for the cerebral hemisphere falls, suggesting 
that oxidative phosphorylation has been recou-
pled.47 48 Three controlled clinical trials have been 
reported; in tw049 so glycerol therapy was com-
pared with the non-specific supportive measures 
employed in the management of strokes and in one 
with dexamethasone.sl All three used a scoring sys-
tem which evaluated mentation, orientation, 
speech, motor, sensory, and reflex activity, and 
"performance disability". None showed significant 
reduction in mortality; all showed an improvement 
in the neurological evaluation score which in onel7 
was limited to the group with the intermediate 
score. One patient died of hlEmoglobinuria and 
renal failure as a result of the glycerol therapy.18 
The results, though indicating the need for further 
investigations, are not encouraging. Neurological 
evaluation scores are notoriously difficult to devise. 
For example, facial weakness, though disfiguring, 
does not add to a patient'S disability to the same 
degree as does weakness of the limbs, yet in one of 
the trials18 both are rated the same. In none of the 
trials is there clear evidence that patients who 
might otherwise have been bed-ridden were able to 
achieve a wheel-chair life, or those who might only 
have been able to walk with help became indepen-
dent. 
Further trials will be required in which particu-
lar effort should be made to distinguish more pre-
cisely the type of lesion responsible for the stroke. 
For example, the clinical picture produced by a 
large infarction (such as results from occlusion of 
the main trunk of the middle cerebral artery) and 
45. Hossmann, K-A., Sato, K. SciDu:t, 1970,168,375. 
46. Hossmann. K-A., Kleibues, P. Arch, Nevro/. 1973,29, 375 . 
. r;. \1eyer, J. S .• Cham~DI J. Z., RI\'cra, .\1.., .\13lhCVo', S. T. Lanu!, 1971. ii. 
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.g .. \-Iever, J. S., Fukuuehi, Y., Sbimazu, K., Ohuchi, T., Ericsson. A. D. S,roke. 
i 972,3, 168. 
49 .. ".I.thew, S. T., .".Ieyer, J. S., Rivera, V .. \\., Charney, J. Z., Ha:tmann. A. 
Lancec, 1972. ii,1327. 
50. crithz~d .• ternerKlKACfnmedKscllndK19T~I 198.,28:'. 
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that caused by a small lacunar lesion in the inter-
nal capsule are broadly similar, though differing in 
detail. The former is very liable to be complicated 
by massive cerebral <:edema, the latter not so. Un-
less these are separated in a clinical trial of an 
anti-redema agent the results are likely to be mis-
leading. Differentiation of these two types of lesion 
should now be possible with the aid of the EM!-
scan. On the assessment side, whilst evaluation of 
neurological status should continue, there should 
be separate assessment of functional capacity-
bed-bound, chair-bound, dependent walking, self-
care, independent-according to one of the scales 
in common use. 52 
SENSE OF HUMOUR 
How can sense of humour (S.O.H.) be evaluated, and 
would its measurement serve medical purposes? The 
appropriate procedure is clearly to challenge the patient 
with humorous material (H.M.) and assess the response. 
Now the preparation and characterisation of H.M. is no 
easy task, even with the resources of modern expertise. 
It is vexingly labile material, degenerating entirely on 
isolation. Consider, for instance, how Bergson'sS3 specifi-
cation might work. The trousers of the vain, pompous 
man fall half down. This makes him seem mechanical, 
and is comic. It happens again: repetition, and comic. 
They fall completely: the snowball effect, and comic. 
They go up again of themselves: reversal, and comic. 
Simultaneously his neighbour's trousers fall: reciprocal 
interference, and comic. But somehow at the end of the 
isolation procedure not much H .. \\. remains. 
Adaptation to H.M. is clearly a nuisance; we cannot 
challenge the same patient a second time with the same 
preparation of H.M., since a single repetition can tum 
H.M. into a chestnut. Thus testing reproducibility of re-
sponse is hard, and it is not easy to decide, for example, 
whether S.O.H. shows a circadian rhythm. Would the joke 
that fails at 2200 h succeed at 1000 h?-we cannot 
easily tell. Another problem is that the active groups of 
H.M. alter from year to year. It is common knowledge 
that Punch is never what it was. And H.M.varies from 
country to country. Punch has little to export to the 
New Yorker, and conversely. Bergson" in France 
reported that people tripping up in the street or l.osing 
their hats were laughable. bysenk~4 took the trouble to 
observe the effect of a few such incidents in London. No 
one laughed. 
Determining the dose/response relation is a source of 
difficulty. Lesser responses are detected only by applying 
a sensitive questionnaire to the patient. Grosser re-
sponses appear as grins, chuckles, or outright laughter. 
There are strange potentations when twO can share a 
joke. The procedure may not even be entirely safe; 
sources of H.M. such as Gerard Hoffnung's immortal 
speech to the Oxford Union, still available on record, 
may for some subjects be so potent as to merit a Govern-
ment Health Warning, and readers of Oliver Wendell 
52 . .\\arquardscn. J . . -fel" ?f~lfroDK Icana. 1969,45, supp!. 38. 
<'.Bergson. H. Le Rire. Pam, 1911. 
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